TOTAL COMPLEMENT ACTIVITY INCREASED

This adverse event was reported 53 times

These drugs are most commonly taken by patients reporting TOTAL COMPLEMENT ACTIVITY INCREASED:

# Drug Count
0 ECULIZUMAB 39
1 ERGOCALCIFEROL 3
2 RAVULIZUMAB 3
3 AMLODIPINE 2
4 CALCIUM CARBONATE 2
5 FUROSEMIDE 2
6 PANTOPRAZOLE 2
7 PREDNISONE 2
8 TACROLIMUS 2
9 TACROLIMUS EXTENDED-RELEASE CAPSULES 2
See all common drugs associated with TOTAL COMPLEMENT ACTIVITY INCREASED

TOTAL COMPLEMENT ACTIVITY INCREASED is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 DELANDISTROGENE MOXEPARVOVEC-ROKL 1 0.0027
1 ZAFIRLUKAST 1 0.0011
2 ECULIZUMAB 39 0.0007
3 IRON DEXTRAN 1 0.0007
4 PEGCETACOPLAN 1 0.0005
5 PREDNISOLONE SODIUM PHOSPHATE 1 0.0004
6 NICARDIPINE 1 0.0002
7 BELATACEPT 1 0.0002
8 MILNACIPRAN HYDROCHLORIDE 1 0.0002
9 PYRIDOSTIGMINE BROMIDE 1 0.0001
See all drugs enriched for association with TOTAL COMPLEMENT ACTIVITY INCREASED

TOTAL COMPLEMENT ACTIVITY INCREASED is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 CD19-directed Cytolytic Antibody [EPC] 1 0.0012
1 Complement Inhibitor [EPC] 42 0.0007
2 Selective T Cell Costimulation Blocker [EPC] 1 0.0002
3 Provitamin D2 Compound [EPC] 3 0.0001
4 Vitamin D3 Analog [EPC] 1 0.0000
5 Alkaloid [EPC] 1 0.0000
6 Leukotriene Receptor Antagonist [EPC] 1 0.0000
7 Tetracycline-class Drug [EPC] 1 0.0000
8 Azole Antifungal [EPC] 2 0.0000
9 Nitrate Vasodilator [EPC] 1 0.0000
See all drug classes enriched for association with TOTAL COMPLEMENT ACTIVITY INCREASED